Wang Sisi, Hu Chunhong, Wu Fang, He Shasha
Department of Oncology, The Second Xiangya Hospital, Central South University, Changsha, Hunan, China.
Oncotarget. 2017 Jul 26;8(38):64591-64599. doi: 10.18632/oncotarget.19571. eCollection 2017 Sep 8.
Rab25, a small GTPase belongs to the Rab protein family, has a pivotal role in cancer pathophysiology. Rab25 governs cell-surface receptors recycling and cellular signaling pathways activation, allowing it to control a diverse range of cellular functions, including cell proliferation, cell motility and cell death. Aberrant expression of Rab25 was linked to cancer development. Majority of research findings revealed that Rab25 is an oncogene. Elevated expression of Rab25 was correlated with poor prognosis and aggressiveness of renal, lung, breast, ovarian and other cancers. However, tumor suppressor function of Rab25 was reported in several cancers, such as colorectal cancer, indicating the tumor type-specific function of Rab25. In this review, we recapitulate the current knowledge of Rab25 in cancer development and therapy.
Rab25是一种属于Rab蛋白家族的小GTP酶,在癌症病理生理学中起着关键作用。Rab25调控细胞表面受体循环和细胞信号通路激活,使其能够控制多种细胞功能,包括细胞增殖、细胞迁移和细胞死亡。Rab25的异常表达与癌症发展有关。大多数研究结果表明Rab25是一种癌基因。Rab25表达升高与肾、肺、乳腺、卵巢及其他癌症的预后不良和侵袭性相关。然而,在一些癌症如结直肠癌中报道了Rab25的肿瘤抑制功能,这表明Rab25具有肿瘤类型特异性功能。在本综述中,我们总结了目前关于Rab25在癌症发展和治疗方面的知识。